Jessica C Cardenas
 
																	
																		 
																	
																		
																	 
																	
																		 
																	
																		
																	 
																	
																			
																					
    
        
            | Title | Associate Professor | 
|---|
 | Institution | University of Colorado Denver - Anschutz Medical Campus | 
|---|
 | Department | SOM-SRG | 
|---|
 
  |  
  
         | 
        
            
         | 
     
 
																				
																					
																				
																					  Research  R35GM146859     (CARDENAS, JESSICA)Aug 1, 2022 - May 31, 2027 NIH Endothelial regulation of inflammation in trauma and hemorrhagic shock Role: Principal Investigator |  
  |  F32HL120549     (CARDENAS, JESSICA)Aug 1, 2014 - Jul 31, 2016 NIH Role of GPIba Receptor Shedding in Platelet Dysfunction Following Trauma Role: Principal Investigator |  
  
  Bibliographic  
	
	
   
    
	
				
			
				
					
				- 
					
						Takahashi K, Yamakawa K, Siletz AE, Katsura M, Holcomb JB, Wade CE, Cardenas JC, Fox EE, Schellenberg M, Martin M, Inaba K, Matsushima K. Hyperfibrinolysis: a crucial phenotypic abnormality of posttraumatic fibrinolytic dysfunction. Res Pract Thromb Haemost. 2024 Oct; 8(7):102568. PMID: 39430866.
					 
					
				 
					
				- 
					
						Richter RP, Odum JD, Margaroli C, Cardenas JC, Zheng L, Tripathi K, Wang Z, Arnold K, Sanderson RD, Liu J, Richter JR. Trauma promotes heparan sulfate modifications and cleavage that disrupt homeostatic gene expression in microvascular endothelial cells. Front Cell Dev Biol. 2024; 12:1390794. PMID: 39114570.
					 
					
				 
					
				- 
					
						Cereceda L, Cardenas JC, Khoury M, Silva-Pavez E, Hidalgo Y. Impact of platelet-derived mitochondria transfer in the metabolic profiling and progression of metastatic MDA-MB-231 human triple-negative breast cancer cells. Front Cell Dev Biol. 2023; 11:1324158. PMID: 38283990.
					 
					
				 
					
				- 
					
						Drake WP, Hsia C, Samavati L, Yu M, Cardenas J, Gianella FG, Boscardin J, Koth LL. Risk Indicators of Sarcoidosis Evolution-Unified Protocol (RISE-UP): protocol for a multi-centre, longitudinal, observational study to identify clinical features that are predictive of sarcoidosis progression. BMJ Open. 2023 04 03; 13(4):e071607. PMID: 37012011.
					 
					
				 
					
				- 
					
						Magallon RE, Harmacek LD, Arger NK, Grewal P, Powers L, Werner BR, Barkes BQ, Li L, MacPhail K, Gillespie M, White EK, Collins SE, Brown T, Cardenas J, Chen ES, Maier LA, Leach SM, Hamzeh NY, Koth LL, O'Connor BP. Standardization of flow cytometry and cell sorting to enable a transcriptomic analysis in a multi-site sarcoidosis study. PLoS One. 2023; 18(3):e0281210. PMID: 36893197.
					 
					
				 
					
				- 
					
						Pretorius D, Richter RP, Anand T, Cardenas JC, Richter JR. Alterations in heparan sulfate proteoglycan synthesis and sulfation and the impact on vascular endothelial function. Matrix Biol Plus. 2022 Dec; 16:100121. PMID: 36160687.
					 
					
				 
					
				- 
					
						Pati S, Fennern E, Holcomb JB, Barry M, Trivedi A, Cap AP, Martin MJ, Wade C, Kozar R, Cardenas JC, Rappold JF, Spiegel R, Schreiber MA. Treating the endotheliopathy of SARS-CoV-2 infection with plasma: Lessons learned from optimized trauma resuscitation with blood products. Transfusion. 2021 07; 61 Suppl 1:S336-S347. PMID: 34269437.
					 
					
				 
					
				- 
					
						Rahbar E, Cotton BA, Wade CE, Cardenas JC. Acquired antithrombin deficiency is a risk factor for venous thromboembolism after major trauma. Thromb Res. 2021 08; 204:9-12. PMID: 34091120.
					 
					
				 
					
				- 
					
						Holcomb JB, Sauaia A, Cardenas JC. Tranexamic Acid and Safety in the Right Patient. JAMA Surg. 2021 Apr 14; e210929. PMID: 33851968.
					 
					
				 
					
				- 
					
						Lopez E, Peng Z, Kozar RA, Cao Y, Ko TC, Wade CE, Cardenas JC. Antithrombin III Contributes to the Protective Effects of Fresh Frozen Plasma Following Hemorrhagic Shock by Preventing Syndecan-1 Shedding and Endothelial Barrier Disruption. Shock. 2020 02; 53(2):156-163. PMID: 31389906.
					 
					
				 
					
				- 
					
						Cardenas JC, Wang YW, Karri JV, Vincent S, Cap AP, Cotton BA, Wade CE. Supplementation with antithrombin III ex vivo optimizes enoxaparin responses in critically injured patients. Thromb Res. 2020 03; 187:131-138. PMID: 31986476.
					 
					
				 
					
				- 
					
						Blackburn SL, Kumar PT, McBride D, Zeineddine HA, Leclerc J, Choi HA, Dash PK, Grotta J, Aronowski J, Cardenas JC, Doré S. Unique Contribution of Haptoglobin and Haptoglobin Genotype in Aneurysmal Subarachnoid Hemorrhage. Front Physiol. 2018; 9:592. PMID: 29904350.
					 
					
				 
					
				- 
					
						White NJ, Wang Y, Fu X, Cardenas JC, Martin EJ, Brophy DF, Wade CE, Wang X, St John AE, Lim EB, Stern SA, Ward KR, López JA, Chung D. Post-translational oxidative modification of fibrinogen is associated with coagulopathy after traumatic injury. Free Radic Biol Med. 2016 07; 96:181-9. PMID: 27105953.
					 
					
				 
					
				- 
					
						Sarkissyan S, Sarkissyan M, Wu Y, Cardenas J, Koeffler HP, Vadgama JV. IGF-1 regulates Cyr61 induced breast cancer cell proliferation and invasion. PLoS One. 2014; 9(7):e103534. PMID: 25062088.
					 
					
				 
					
				- 
					
						Matijevic N, Wang YW, Wade CE, Holcomb JB, Cotton BA, Schreiber MA, Muskat P, Fox EE, Del Junco DJ, Cardenas JC, Rahbar MH, Cohen MJ. Cellular microparticle and thrombogram phenotypes in the Prospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study: correlation with coagulopathy. Thromb Res. 2014 Sep; 134(3):652-8. PMID: 25086657.
					 
					
				 
		
				 	
			 				
		
	
			
		This graph shows the total number of publications by year, by first, middle/unknown, or last author.
		 
			 
            To see the data from this visualization as text,  click here. 
		 
        
		    | Year | Publications | 
|---|
 | 2014 | 2 |  | 2016 | 1 |  | 2018 | 1 |  | 2020 | 2 |  | 2021 | 3 |  | 2022 | 1 |  | 2023 | 2 |  | 2024 | 3 |  
 
            To return to the timeline,  click here.
         
             
	 	
 
	
 
  
																				
																					
	
 
																				
                                                                            
																		
																	 
																 
															 | 
		
																
																	
																		
																			
																					
    Cardenas's Networks
 
Click the "See All" links for more information and interactive visualizations!
 
																				
																					Concepts   Derived automatically from this person's publications. _ 
																				
																					Co-Authors   People in Profiles who have published with this person. _ 
																				
																					Similar People   People who share similar concepts with this person. _ 
																				
																					
        
            
                Same Department  
                     
                
             
            
				People who are also in this person's primary department.
			 
                 
        
    
																				
																					
																				
																					
																				
																		
																	 
																 
															 |